Andrew J. Einhorn insider trades

Open-market stock purchases and sales by Andrew J. Einhorn, Director at Pelthos Therapeutics Inc, from SEC Form 4 filings since Oct 6, 2015.

Recent trades

DateStockTradeValue
Dec 23, 2025PTHS Pelthos Therapeutics IncBought (not open market)—

Companies traded

  • PTHS Pelthos Therapeutics Inc: other filings, last Dec 23, 2025
  • RVLP RVL Pharmaceuticals plc: other filings, last Jan 24, 2022
  • OSMT Osmotica Pharmaceuticals plc: other filings, last Nov 4, 2021
  • EDGE Edge Therapeutics, Inc: 1 buy, last Mar 1, 2017

Get free alerts when Andrew J. Einhorn files a new trade →